Literature DB >> 25554586

Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.

Victoria M Pratt1, Brittany N Beyer2, Daniel L Koller2, Todd C Skaar3, David A Flockhart3, Kenneth D Levy3, Gail H Vance2.   

Abstract

The ATP-binding cassette, subfamily C [CFTR/MRP], member 2 (ABCC2) gene is a member of the ATP-binding cassette transporters and is involved in the transport of molecules across cellular membranes. Substrates transported by ABCC2 include antiepileptics, statins, tenofovir, cisplatin, irinotecan, and carbamazepine. Because of the pharmacogenomics implications, we developed a clinical laboratory-developed assay to test for seven variants in the ABCC2 gene: c.3563T>A (p.V1188E, rs17222723), c.1249G>A (p.V417I, rs2273697), c.3972C>T (p.I1324I, rs3740066), c.2302C>T (p.R768W, rs56199535), c.2366C>T (p.S789F, rs56220353), c.-24C>T (5'UTR, rs717620), and c.4544G>A (p.C1515Y, rs8187710). During the validation process, we noted several DNA samples, obtained from the Coriell Cell Repository, that contained both c.3563T>A, c.4544G>A, and a third variant, suggesting that c.3563T>A and c.4544G>A are in cis on the chromosome in some individuals. We obtained DNA samples from a trio (father, mother, and child), tested their ABCC2 variants, and confirmed that c.3563T>A and c.4544G>A were in cis on the same chromosome. Here, we report a new haplotype in ABCC2.
Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25554586      PMCID: PMC4348475          DOI: 10.1016/j.jmoldx.2014.11.005

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  20 in total

1.  Readmissions and adverse drug reactions in internal medicine: the economic impact.

Authors:  H Dormann; A Neubert; M Criegee-Rieck; T Egger; M Radespiel-Tröger; T Azaz-Livshits; M Levy; K Brune; E G Hahn
Journal:  J Intern Med       Date:  2004-06       Impact factor: 8.989

2.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

3.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

4.  Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome.

Authors:  R Mor-Cohen; A Zivelin; N Rosenberg; M Shani; S Muallem; U Seligsohn
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

5.  Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.

Authors:  S Toh; M Wada; T Uchiumi; A Inokuchi; Y Makino; Y Horie; Y Adachi; S Sakisaka; M Kuwano
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

6.  Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome.

Authors:  M Wada; S Toh; K Taniguchi; T Nakamura; T Uchiumi; K Kohno; I Yoshida; A Kimura; S Sakisaka; Y Adachi; M Kuwano
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

7.  Lack of association between ABCC2 gene variants and treatment response in epilepsy.

Authors:  Eva Hilger; Eva Maria Reinthaler; Elisabeth Stogmann; Christoph Hotzy; Ekaterina Pataraia; Christoph Baumgartner; Alexander Zimprich; Fritz Zimprich
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

Review 8.  Dubin-Johnson and Rotor syndromes: molecular basis and pathogenesis.

Authors:  P Zimniak
Journal:  Semin Liver Dis       Date:  1993-08       Impact factor: 6.115

9.  Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2.

Authors:  Masakazu Hirouchi; Hiroshi Suzuki; Masaya Itoda; Shogo Ozawa; Jun-ichi Sawada; Ichiro Ieiri; Kenji Ohtsubo; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

10.  Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.

Authors:  T D Nguyen; S Markova; W Liu; J M Gow; R M Baldwin; M Habashian; M V Relling; M J Ratain; D L Kroetz
Journal:  Pharmacogenomics J       Date:  2012-06-05       Impact factor: 3.550

View more
  1 in total

1.  New ABCC2 rs3740066 and rs2273697 Polymorphisms Identified in a Healthy Colombian Cohort.

Authors:  Rosa Helena Bustos-Cruz; Luis Rafael Martínez; Julio César García; George E Barreto; Fernando Suárez
Journal:  Pharmaceutics       Date:  2018-07-17       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.